Chelerythrin activates caspase‐8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor‐related apoptosis‐inducing ligand in KG1a cells
Uwe Platzbecker(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), H. Joachim Deeg(University of Washington)
Cited by 22
Related Papers
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
|Leukemia|2011|395
The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes
|Blood|2010|55